Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Systematic Reviews
Published in: Systematic Reviews 1/2017

Open Access 01-12-2017 | Protocol

Does metabolic syndrome predict surgical complications? A protocol for a systematic review and meta-analysis

Authors: Philip Norris, Nicholas Ralph, Clint Moloney

Published in: Systematic Reviews | Issue 1/2017

Login to get access

Abstract

Background

Metabolic syndrome (MetS) is defined by an accumulation of risk factors that include cardiovascular disease, diabetes, chronic high blood pressure, obesity, and hypercholesterolaemia which results in an increased risk of developing serious chronic diseases. MetS is widespread as it is estimated to affect up to 30% of the global population. For people with MetS who undergo surgery, an emerging body of literature points to significantly poorer postoperative outcomes compared with non-affected populations. Surgical patients with MetS are at significantly higher risk of a range of adverse outcomes including death, morbid cardiovascular events, coma, stroke, renal failure, myocardial infarction, and surgical site infections. Increased complication rates result in prolonged hospital stays, a greater need for post-hospitalisation care, and reduced effectiveness of surgical interventions.

Methods/design

We will search the following electronic bibliographic databases: MEDLINE, EMBASE, ScienceDirect, and CINAHL, and the reference lists of included articles. We will also search for unpublished literature. Two authors will screen titles and abstract information independently and select studies according to established inclusion and exclusion criteria. Data will be extracted by the study investigators using Review Manager 5 and will include information on demographics, incidence, prevalence, and outcome variables. Subgroup analysis and sensitivity analysis will be performed to assess the heterogeneity of included studies. Meta-analysis will also be carried out if appropriate study groups are identified. A descriptive narrative for statistical data will also be provided to highlight findings of the systematic review and meta-analysis.

Discussion

This study will report and summarise adverse outcomes among adult patients with MetS undergoing surgery across a range of surgical specialties. Developing insights into outcomes of this population of interest is necessary to develop guidelines towards better management of surgical patients with metabolic syndrome.

Systematic review registration

PROSPERO CRD42016051071
Appendix
Available only for authorised users
Literature
1.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed
2.
O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1–12.CrossRefPubMed
3.
Alberti KG, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.CrossRefPubMed
4.
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 2002. 106(25): 3143-421.
5.
Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28(11):2745–9.CrossRefPubMed
6.
Sookoian S, Pirola CJ. Metabolic syndrome: from the genetics to the pathophysiology. Curr Hypertens Rep. 2011;13(2):149–57.CrossRefPubMed
7.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
8.
Glance LG, et al. Perioperative outcomes among patients with the modified metabolic syndrome who are undergoing noncardiac surgery. Anesthesiology. 2010;113(4):859–72.CrossRefPubMed
9.
Porrini E, Delgado P, Torres A. Metabolic syndrome, insulin resistance, and chronic allograft dysfunction. Kidney Int Suppl. 2010;119:S42–6.CrossRef
10.
Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. Am J Med. 2006;119(10):812–9.CrossRefPubMed
11.
Zmistowski B, et al. Patients with uncontrolled components of metabolic syndrome have increased risk of complications following total joint arthroplasty. J Arthroplasty. 2013;28(6):904–7.CrossRefPubMed
12.
Peng F, et al. Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study. Int J Cancer. 2016;139(12):2705–13.CrossRefPubMed
13.
Menendez ME, et al. The impact of metabolic syndrome on inpatient outcomes after isolated ankle fractures. Foot Ankle Int. 2014;35(5):463–70.CrossRefPubMed
14.
Ardeshiri M, et al. Impact of metabolic syndrome on mortality and morbidity after coronary artery bypass grafting surgery. Res Cardiovasc Med. 2014;3(3):e20270.CrossRefPubMedPubMedCentral
15.
Porrini E, et al. Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation. Am J Kidney Dis. 2006;48(1):134–42.CrossRefPubMed
16.
Kajimoto K, et al. Metabolic syndrome predicts 10-year mortality in non-diabetic patients following coronary artery bypass surgery. Circ J. 2008;72(9):1481–6.CrossRefPubMed
17.
Echahidi N, et al. Obesity and metabolic syndrome are independent risk factors for atrial fibrillation after coronary artery bypass graft surgery. Circulation. 2007;116(11 Suppl):I213–9.PubMed
18.
Brackbill ML, Sytsma CS, Sykes K. Perioperative outcomes of coronary artery bypass grafting: effects of metabolic syndrome and patient’s sex. Am J Crit Care. 2009;18(5):468–73.CrossRefPubMed
19.
Echahidi N, et al. Metabolic syndrome increases operative mortality in patients undergoing coronary artery bypass grafting surgery. J Am Coll Cardiol. 2007;50(9):843–51.CrossRefPubMed
20.
Pimenta E, et al. Metabolic syndrome in patients undergoing coronary artery bypass graft: prevalence and a marker of morbidity/mortality during hospitalization and 30 days after hospital discharge. Arq Bras Cardiol. 2007;88(4):413–7.CrossRefPubMed
21.
Polomsky M, et al. Long-term survival for patients with metabolic syndrome after bioprosthetic or mechanical valve replacement. J Card Surg. 2014;29(1):26–34.CrossRefPubMed
22.
Edelstein AI, et al. The impact of metabolic syndrome on 30-day complications following total joint arthroplasty. J Arthroplasty. 2016;32:362.CrossRefPubMed
23.
Gage MJ, et al. Impact of metabolic syndrome on perioperative complication rates after total joint arthroplasty surgery. J Arthroplasty. 2014;29(9):1842–5.CrossRefPubMed
24.
Gandhi K, et al. Quantifying cardiovascular risks in patients with metabolic syndrome undergoing total joint arthroplasty. J Arthroplasty. 2012;27(4):514–9.CrossRefPubMed
25.
Gonzalez Della Valle A, et al. The metabolic syndrome in patients undergoing knee and hip arthroplasty: trends and in-hospital outcomes in the United States. J Arthroplasty. 2012;27(10):1743–1749.e1.CrossRefPubMed
26.
Gandhi R, et al. Metabolic syndrome and the functional outcomes of hip and knee arthroplasty. J Rheumatol. 2010;37(9):1917–22.CrossRefPubMed
27.
Song K, et al. Metabolic syndrome and deep vein thrombosis after total knee and hip arthroplasty. J Arthroplasty. 2016;31(6):1322–5.CrossRefPubMed
28.
Yilmaz MB, et al. Metabolic syndrome negatively impacts early patency of saphenous vein grafts. Coron Artery dis. 2006;17(1):41–4.CrossRefPubMed
29.
Ozyazicioglu A, et al. Effects of metabolic syndrome on early mortality and morbidity in coronary artery bypass graft patients. J Int Med Res. 2010;38(1):202–7.CrossRefPubMed
30.
Memtsoudis SG, et al. Metabolic syndrome and lumbar spine fusion surgery: epidemiology and perioperative outcomes. Spine (Phila Pa 1976). 2012;37(11):989–95.CrossRef
31.
Ballantyne GH, et al. Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome. Obes Surg. 2004;14(8):1042–50.CrossRefPubMed
32.
Chang AL, et al. Metabolic syndrome in liver transplantation: a preoperative and postoperative concern. Surgery. 2016;160(4):1111–7.CrossRefPubMed
33.
Shiota M, et al. The differential impact of body mass index and the feature of metabolic syndrome on oncological outcomes following different surgical procedures in Japanese men with prostate cancer. Ann Surg Oncol. 2016;24:1443.CrossRefPubMed
34.
35.
Horan TC, et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol. 1992;13(10):606–8.CrossRefPubMed
36.
Reuters T. EndNote X7. Philadelphia: Thomson Reuters; 2013.
37.
Cochrane Collaboration. Review Manager (RevMan). 2011, Cochrane Collaboration.
38.
39.
40.
Stroup DF, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA. 2000;283(15):2008–12.CrossRefPubMed
Metadata
Title
Does metabolic syndrome predict surgical complications? A protocol for a systematic review and meta-analysis
Authors
Philip Norris
Nicholas Ralph
Clint Moloney
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Systematic Reviews / Issue 1/2017
Electronic ISSN: 2046-4053
DOI
https://doi.org/10.1186/s13643-017-0515-6

Other articles of this Issue 1/2017

Systematic Reviews 1/2017 Go to the issue

Protocol

Fracture risk in dialysis and kidney transplanted patients: a protocol for systematic review and meta-analysis

Protocol

Paraquat and Parkinson’s disease: a systematic review protocol according to the OHAT approach for hazard identification

Research

Diabetes-related information-seeking behaviour: a systematic review

Protocol

Structural barriers in access to medical marijuana in the USA—a systematic review protocol

Protocol

A systematic review of decision aids that facilitate elements of shared decision-making in chronic illnesses: a review protocol

Protocol

Effectiveness of current policing-related mental health interventions in England and Wales and Crisis Intervention Teams as a future potential model: a systematic review